In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 

Removals are routinely completed in outpatient offices, but occasionally when complications make them more challenging, providers turn to additional tools for assistance. 

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.

Researchers at the University of Edinburgh found that cats with dementia, like humans, have protein buildup in synapses that impacts cognitive function and memory.

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

New research published in Lancet Digital Health details the improved cancer detection rates achieved when AI serves as a second reader. 

Local officials are describing the matter as "a deeply regrettable situation."

A new study is the first to show that men with biochemically recurrent prostate cancer who undergo PSMA PET/CT prior to salvage therapy have improved survival rates.